News articles about Safeguard Scientifics (NYSE:SFE) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Safeguard Scientifics earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave news articles about the asset manager an impact score of 44.842578960365 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the news articles that may have effected Accern Sentiment’s rankings:
- Sierra Capital Comments on Safeguard’s (SFE) Adoption of ‘Shareholder-Chilling’ NOL Poison Pill (streetinsider.com)
- Sierra Capital Comments on Safeguard’s Adoption of Shareholder-Chilling NOL Poison Pill (finance.yahoo.com)
- Safeguard Scientifics Adopts Tax Benefits Preservation Plan To Protect Valuable Tax Assets (finance.yahoo.com)
- Safeguard Scientifics (SFE) Stock Rating Lowered by Zacks Investment Research (americanbankingnews.com)
- UPDATE: Safeguard Scientifics (SFE) Issues Statement in Response to Sierra and Yakira (streetinsider.com)
Shares of Safeguard Scientifics (NYSE SFE) traded up $0.12 on Thursday, hitting $11.37. 6,679 shares of the stock traded hands, compared to its average volume of 135,465. The firm has a market cap of $227.60, a PE ratio of -2.53 and a beta of 1.36. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.03 and a quick ratio of 1.03. Safeguard Scientifics has a 12 month low of $10.65 and a 12 month high of $14.40.
ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Safeguard Scientifics (SFE) Share Price” was originally reported by BBNS and is the sole property of of BBNS. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://baseballnewssource.com/markets/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-safeguard-scientifics-sfe-share-price/1902152.html.
About Safeguard Scientifics
Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.